We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLVRW
3151
CALL
DELISTED
Clever Leaves Holdings Inc. Warrant
CLVRW
$124K ﹤0.01%
50,000
GROW icon
3152
US Global Investors
GROW
$37.2M
$123K ﹤0.01%
23,736
-16,048
-40% -$83.9K
NGD
3153
DELISTED
New Gold Inc
NGD
$121K ﹤0.01%
+67,694
New +$116K
TRON
3154
DELISTED
Corner Growth Acquisition Corp. 2 Class A Ordinary Share
TRON
$121K ﹤0.01%
12,171
RSKD icon
3155
Riskified
RSKD
$720M
$120K ﹤0.01%
19,880
-237,871
-92% -$1.59M
JG
3156
Aurora Mobile
JG
$30.9M
$118K ﹤0.01%
5,397
-34,609
-87% -$702K
OPTXW icon
3157
CALL
Syntec Optics Holdings Warrant
OPTXW
$14.1M
$117K ﹤0.01%
+11,657
New +$2.85K
BZAI
3158
Blaize Holdings
BZAI
$122M
$115K ﹤0.01%
+11,500
New +$113K
MFG icon
3159
Mizuho Financial
MFG
$123B
$114K ﹤0.01%
44,384
+6,719
+18% +$18.4K
FXE icon
3160
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
$112K ﹤0.01%
1,087
-100
-8% -$10.4K
RES icon
3161
RPC Inc
RES
$1.14B
$111K ﹤0.01%
10,416
-2,078
-17% -$16.6K
OMIC
3162
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$111K ﹤0.01%
582
-1,666
-74% -$385K
DARE icon
3163
Dare Bioscience
DARE
$17.8M
$110K ﹤0.01%
6,140
-109,574
-95% -$2.07M
MITT
3164
TPG Mortgage Investment Trust
MITT
$230M
$110K ﹤0.01%
+11,853
New +$114K
SPOK icon
3165
Spok Holdings
SPOK
$227M
$109K ﹤0.01%
13,650
-60,155
-82% -$546K
AMYT
3166
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$108K ﹤0.01%
+12,994
New +$117K
SKIL icon
3167
Skillsoft
SKIL
$63.8M
$107K ﹤0.01%
+891
New +$123K
THRN
3168
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$107K ﹤0.01%
16,810
-1,142
-6% -$6.15K
OTLY
3169
Oatly Group
OTLY
$473M
$105K ﹤0.01%
+1,050
New +$138K
AUD
3170
DELISTED
Audacy, Inc.
AUD
$104K ﹤0.01%
+36,264
New +$95.7K
IGV icon
3171
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$12.3B
$103K ﹤0.01%
1,500
MAAS
3172
Maase Inc
MAAS
$7.56B
$101K ﹤0.01%
291
-86
-23% -$33.7K
TCS
3173
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$101K ﹤0.01%
824
-654
-44% -$90.8K
ERAS icon
3174
Erasca
ERAS
$6.3B
$98K ﹤0.01%
+11,401
New +$132K
LIAN
3175
DELISTED
LianBio American Depositary Shares
LIAN
$98K ﹤0.01%
26,457
-126,491
-83% -$522K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.